The risk for readmission in schizophrenia patients treated with long-acting injectable (typical or atypical) versus oral antipsychotics

被引：0
|
作者：
Onn, R. [1 ]
Krivoy, A. [1 ,2 ]
Weizman, A. [1 ,2 ]
Hochman, E. [1 ,2 ]
Valevski, A. [1 ,2 ]
机构：
[1] Geha Mental Hlth Ctr, Psychiat, Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2015年 / 25卷
关键词：
D O I：
10.1016/S0924-977X(15)30676-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.027
引用
收藏
页码：S494 / S494
页数：1
相关论文
共 50 条
  • [1] Long-acting injectable versus oral antipsychotics for schizophrenia
    Munkholm, Klaus
    LANCET PSYCHIATRY, 2021, 8 (07): : 566 - 567
  • [2] Cognitive Outcomes in Nonacute Patients With Schizophrenia Treated With Long-Acting Injectable Antipsychotics Versus Oral Antipsychotics
    Petric, Paula Simina
    Teodorescu, Andreea
    Miron, Ana Aliana
    Manea, Mihnea Costin
    Ifteni, Petru
    AMERICAN JOURNAL OF THERAPEUTICS, 2024, 31 (03) : e219 - e228
  • [3] Long-acting injectable versus oral antipsychotics for schizophrenia reply
    Kishimoto, Taishiro
    Hagi, Katsuhiko
    Kurokawa, Shunya
    Kane, John M.
    Correll, Christoph U.
    LANCET PSYCHIATRY, 2021, 8 (07): : 567 - 567
  • [4] Analysis of Oral versus Long-acting Injectable Antipsychotics in the Maintenance of Schizophrenia
    Vasiliu, O.
    EUROPEAN PSYCHIATRY, 2022, 65 : S322 - S322
  • [5] Hospital Readmission Rates Among Patients With Schizophrenia Treated With Long-Acting Injectables or Oral Antipsychotics
    MacEwan, Joanna P.
    Kamat, Siddhesh A.
    Duffy, Ruth A.
    Seabury, Seth
    Chou, Jacquelyn W.
    Legacy, Susan N.
    Hartry, Ann
    Eramo, Anna
    Karson, Craig
    PSYCHIATRIC SERVICES, 2016, 67 (11) : 1183 - 1188
  • [6] Time to Rehospitalization in Patients With Schizophrenia Receiving Long-Acting Injectable Antipsychotics or Oral Antipsychotics
    Lin, Ching-Hua
    Chen, Feng-Chua
    Chan, Hung-Yu
    Hsu, Chun-Chi
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2019, 22 (09): : 541 - 547
  • [7] Benzodiazepines and Mood Stabilizers in Schizophrenia Patients Treated with Oral versus Long-Acting Injectable Antipsychotics-An Observational Study
    Miron, Ana Aliana
    Petric, Paula Simina
    Teodorescu, Andreea
    Ifteni, Petru
    Chele, Gabriela
    Szalontay, Andreea Silvana
    BRAIN SCIENCES, 2023, 13 (02)
  • [8] Satisfaction of patients and caregivers with long-acting injectable risperidone and oral atypical antipsychotics
    Han, CS
    Lee, BH
    Kim, YK
    Lee, HJ
    Kim, SH
    Kim, L
    Lee, MS
    Joe, SH
    Ham, BJ
    Jung, IK
    PRIMARY CARE & COMMUNITY PSYCHIATRY, 2005, 10 (03) : 119 - 124
  • [9] Comparison of oral atypical Antipsychotics to a long-acting injectable atypical antipsychotic in patients with bipolar disorder
    Binder, C
    Fallu, A
    Yatham, LN
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 203S - 203S
  • [10] Long-acting injectable antipsychotics versus oral antipsychotics for treatment of schizophrenia: French clinical and economical comparison
    Amsallem, A.
    Bonnet, C.
    Morgny, C.
    Vandel, P.
    Tissot, E.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S320 - S320
12345